technology -- and is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown to be effective in a variety of wounds and burns, and was the focus of a positive large-scale randomized controlled trial on leg ulcers. Derma's recently FDA cleared BIOGUARD(TM) Barrier Dressing is the Company's latest new product entrant into the $14 billion global wound care market. The barrier technology was licensed from Quick-Med Technologies, Inc. in Q1 of 2007. Derma also has in development DSC127, a novel angiotensin analog for accelerated wound healing and scar reduction. DSC127 was licensed from the
University of Southern California in Q4 of 2007. Patient enrollment for a Phase II study began in Q4 of 2008. Results from this study are expected to be submitted to the FDA in Q2 of 2010.
For more information about Derma Sciences, Inc., visit http://www.dermasciences.com.
Contact:
Derma Sciences, Inc.
Edward J. Quilty
Chairman and CEO
equilty@dermasciences.com
(609) 514-4744
Allen & Caron Inc
Rudy Barrio (US Investors)
r.barrio@allencaron.com
(212) 691-8087
Brian Kennedy (Media)
brian@allencaron.com
(212) 691-8087
'/>"/>SOURCE Derma Sciences, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related medicine news :1.
American Academy of Dermatology Association Commends Texas for Enacting the Most Restrictive Indoor Tanning Law in the Country2.
Florida Dermatologists Announce Distinguished Service Award Winner3.
Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle-free Symphony(TM) Transdermal Continuous Glucose Monitoring System4.
New State of the Art Dermatology Center in Plano TX5.
Video: BeautyScoop(R) Is a Trip to Your Nutritionist and Dermatologist in One Single Packet. Lauren Slayton, NYC Nutritionist & Owner of FoodTrainers6.
Florida Dermatologists Name Albert J. Nemeth, MD, Society President7.
Florida Dermatologists Announce Practitioner of the Year8.
American Academy of Dermatology Issues New Guidelines For the Management of Psoriasis With Systemic Medications9.
Orlando Dermatology Aesthetic & Clinical (ODAC) Conference Announces Its 2010 Event10.
American Academy of Dermatology Recognizes Merz Pharmaceuticals11.
Online System Could Cut Referrals to Dermatologists